AnnouncedFiled 21 November 2025
Strategikon Pharma, Inc. raised $2.29M
Strategikon Pharma, Inc., a technology company based in San Francisco, CA, raised $2.29M in a new debt round, according to a filing dated 21 November 2025.
Announced on 10 June 2025, 164 days before the filing. prnewswire.com ↗
- Filed
- 21 November 2025
- Round
- Debt round
- Amount sold
- $2.29M
- Offering size
- $3M
- Investors so far
- 15
- Based in
- San Francisco, CA
- Website
- strategikon.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 22% of the 1,404 tracked raises with an amount filed in 2025, and than 23% of the 711 in technology.
Strategikon Pharma, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 21 Nov 2025 | New filing | $2.29M | This raise |
More with Ovp Vi Aff on the board
- MarginEdge Co.$20.6M
- Incentivio, Inc$3.9M
- Curavit Clinical Research Corp$11.4M
- Connected2Fiber, Inc.$4.5M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.